Sign Up
OverviewAPI
Three oncology companies, Immuneering, Prelude, and Mural Oncology, will present preclinical data at the American Association for Cancer Research annual meeting. Immuneering focuses on universal-RAS/RAF medicines, Prelude presents oral SMARCA2 degrader and CDK inhibitors, and Mural Oncology unveils IL-18 and IL-12 programs for cancer treatment.

Ask a question